FDA Clearance Tracker · K243374
HemosIL CL HIT-IgG(PF4-H)
Last checked: Nov 20, 2026Latest source record: Jan 28, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jan 28, 2025
Substantially Equivalent
Time to decision
90 days
Received Oct 30, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243374
- Device name
- HemosIL CL HIT-IgG(PF4-H)
- Applicant
- Instrumentation Laboratory (IL) Co.
- Applicant location
- Bedford, MA
- Received
- Oct 30, 2024
- Decided
- Jan 28, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Platelet Factor 4 Radioimmunoassay (LCO)
- Device class
- Class II
- Regulation
- 21 CFR 864.7695
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LCO. The earliest in FDA's data is K862774, decided Sep 4, 1986.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243374
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Instrumentation Laboratory (IL) Co.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260551 · Decided Mar 20, 2026 · 30 days after receipt
Device type: Test, Time, Partial Thromboplastin (GGW) · Laboratory Medicine & Pathology
K253957 · Decided Jan 9, 2026 · 30 days after receipt
Device type: Activated Partial Thromboplastin (GFO) · Laboratory Medicine & Pathology
K251968 · Decided Jul 24, 2025 · 28 days after receipt
Device type: System, Fibrinogen Determination (KQJ) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.